AL-15469A for the Treatment of Bacterial Conjunctivitis

Alcon

Status and phase: Completed; Phase 3

Conditions: Bacterial Conjunctivitis

Treatments: Drug: quinolone

Study type: Interventional

Funder types: Industry

Identifiers

NCT00331916

C-04-38

Details and patient eligibility

About

The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.

Enrollment: 600 estimated patients

Sex: All

Ages: 1+ month old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signs & Symptoms of conjunctivitis

Exclusion criteria

• Under 1 mo. age

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind